Showing results (2461-2470 of 4,374) with videos related to

Sort By:
Pageof 438
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 11, 2023
Peer supporters' mental health and emotional wellbeing needs: Key factors and opportunities for co-produced trainingLaura Kane, Robert M Portman, Judith Eberhardt, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
Expanded PCR Panel Testing for Identification of Respiratory Pathogens and Coinfections in Influenza-like IllnessPallavi Upadhyay, Jairus Reddy, Teddie Proctor, et al.
Infection Control and Hospital Epidemiology|January 5, 2002
Physician preferences for continuing medical education with a focus on the topic of antimicrobial resistance: Society for Healthcare Epidemiology of AmericaT T Brown, S E Proctor, R L Sinkowitz-Cochran, et al.
Analytical Methods : Advancing Methods and Applications|March 12, 2021
Use of high resolution/accurate mass full scan/data-dependent acquisition for targeted/non-targeted screening in equine doping controlYouwen You, Rachel M Proctor, Kevin Guo, et al.
Psychopharmacology|August 10, 2006
Midazolam does not inhibit association formation, just its storage and strengtheningLynne M Reder, Iain Proctor, John R Anderson, et al.
Acta Psychologica|July 30, 2019
Response repetitions in auditory task switching: The influence of spatial response distance and of the response-stimulus intervalJulia C Seibold, Iring Koch, Sophie Nolden, et al.
Administration and Policy in Mental Health|October 20, 2010
Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agendaEnola Proctor, Hiie Silmere, Ramesh Raghavan, et al.
Biochemistry|July 12, 2011
Glutathionylation at Cys-111 induces dissociation of wild type and FALS mutant SOD1 dimersRachel L Redler, Kyle C Wilcox, Elizabeth A Proctor, et al.
Journal of Neurosurgery|June 15, 2007
Calvarial defects associated with neurofibromatosis type 1. Report of two casesJohn M K Mislow, Mark R Proctor, P Daniel McNeely, et al.
Proceedings of the Western Pharmacology Society|December 1, 2011
The non-GLP toleration/dose range finding study: design and methodology used in an early toxicology screening programJudith A Herlich, Peter Taggart, Jim Proctor, et al.
Pageof 438